News Articles

New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates TOKYO -Thursday 30 September 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the findings of a study published in the European Journal of Pediatrics in which Dr. Masashi Hotta and colleagues at the Osaka Women’s and Children’s Hospital in Japan found that the Masimo EMMA® Portable Capnograph “may be...

Masimo Launches Single-patient-use rainbow® SuperSensor™ -Tuesday 14 September 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the CE marking and commercial launch in Europe of the single-patient-use adhesive rainbow® SuperSensor™, compatible for use with both Masimo and third-party monitors with Masimo rainbow® technology inside. In an industry first, the...

New Study Investigates the Ability of Masimo ORi™ to Provide Early Warning of Hypoxemia During Endotracheal... -Tuesday 7 September 2021  

(BUSINESS WIRE) -- Masimo (NASDAQ: MASI) announced today the findings of a prospective, blinded observational study published in Annals of Intensive Care in which Dr. Jean-Baptiste Lascarrou and colleagues at the Centre Hospitalier Universitaire in Nantes, France evaluated the ability of...

Masimo Partners with Penington Institute to Raise Awareness of Harm from Prescription Opioid Overdose -Wednesday 1 September 2021  

(BUSINESS WIRE) -- To mark International Overdose Awareness Day (IOAD) on August 31, Masimo (NASDAQ: MASI), a global medical technology company, announced today its commitment to raising awareness of the risks of overdose from prescription opioids, even when used as directed. In December...

Masimo SafetyNet Alert™ Launches in Western Europe -Monday 30 August 2021  

(BUSINESS WIRE) -- Masimo (NASDAQ: MASI) announced today the CE marking and launch in western Europe of Masimo SafetyNet Alert™, an arterial blood oxygen saturation monitoring and alert system designed for use at home. Masimo SafetyNet Alert features Signal Extraction Technology® wearable...

Society for the Advancement of Patient Blood Management (SABM) Publication Recommends Continuous Hemoglobin Monitoring -Saturday 28 August 2021  

(BUSINESS WIRE) -- Masimo (NASDAQ: MASI) announced today the conclusions of a whitepaper published by the Society for the Advancement of Patient Blood Management (SABM) which highlights the importance of continuous hemoglobin (Hgb) monitoring to improve patient outcomes in critical care and...

New Study Evaluates the Use of Masimo PVi® to Monitor Volume Status in Spontaneously Breathing... -Monday 23 August 2021  

(BUSINESS WIRE) -- Masimo (NASDAQ: MASI) announced today the findings of a study published in the Turkish Journal of Emergency Medicine in which Drs. Seda Dağar and Hüseyin Uzunosmanoğlu at the Kecioren Training and Research Hospital in Ankara, Turkey investigated the role that...

New Study Evaluates the Ability of Masimo SedLine® Brain Function Monitoring to Predict Neurological... -Wednesday 7 July 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Critical Care in which Dr. Tae Youn Kim and colleagues at the Dongguk University College of Medicine and Yonsei University College of Medicine in Korea evaluated the ability of two...

New Study Investigates the Impact of ORi-Guided Oxygen Titration on Hyperoxemia-Mediated Morbidity During One-Lung... -Friday 18 June 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the findings of a study published in the Turkish Journal of Medical Sciences in which Dr. Ayten Saracoglu and colleagues at the Marmara University Pendik Training and Research Hospital in Istanbul evaluated the ability of ORi to guide...

New Study Assesses the Effects of Masimo Patient SafetyNet™ on Nursing Workflows in the General Ward -Wednesday 19 May 2021  

(BUSINESS WIRE) -- Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of PeriAnesthesia Nursing in which Drs. Mashasi Ishikawa and Atsuhiro Sakamoto at Nippon Medical School in Tokyo evaluated the utility and impact of Masimo Patient SafetyNet™ by surveying...

Study Investigates the Ability of Masimo O3® to Aid in Monitoring Septic Shock ICU Patients and... -Tuesday 11 May 2021  

(BUSINESS WIRE) -- Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Anesthesia & Clinical Research in which Dr. Debdipta Das and colleagues at Medical College Kolkata in India evaluated the utility of Masimo O3® Regional Oximetry to aid in...

Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal... -Monday 3 May 2021  

(BUSINESS WIRE) -- Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Applied Physiology in which Dr. Marina García-de-Acilu and colleagues at the Vall d’Hebron University Hospital in Barcelona evaluated the utility of Masimo PVi® as a noninvasive...

Study Investigates the Effects of Ventilatory Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients Using... -Wednesday 7 April 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impact of a variety of rescue therapies on the systemic and cerebral oxygenation of mechanically ventilated...

Study Investigates the Impact of Automating Respiration Rate Measurement Using Masimo Rad-G™ with... -Monday 29 March 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Acta Paediatrica in which researchers from the Hospital for Sick Children in Toronto evaluated the accuracy of plethysmographic respiration rate measurement (RRp®) using Masimo...

Sri Lankan Study Expands Evidence Demonstrating the Benefits of Critical Congenital Heart Disease (CCHD) Screening Using... -Monday 22 March 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the results of a prospective study published in the Sri Lanka Journal of Child Health in which researchers in Colombo, Sri Lanka evaluated the efficacy of a pulse oximetry-based critical congenital heart disease (CCHD) newborn screening...

New Study Evaluates the Ability of Masimo EMMA® Capnography to Assess the Respiratory Status of Children With... -Monday 15 March 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the findings of an observational, retrospective study published in Pediatrics International. In the study, researchers at the Osaka Women’s and Children’s Hospital in Japan found the Masimo EMMA® Portable Capnograph “useful for...

Masimo Monitoring Solutions Promote Newborn and Maternal Safety -Thursday 11 March 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety during childbirth and the critical first minutes of life. Masimo SET® pulse oximetry’s ability to measure during motion and low perfusion has helped...

Masimo Announces CE Marking of the Rad-G™ with Temperature -Wednesday 3 March 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the CE marking of the Rad-G™ with Temperature, a rugged handheld device that provides clinically proven SET® pulse oximetry, respiration rate from the pleth (RRp®), and other important parameters alongside clinical-grade, non-contact...

Researchers Use Masimo ORi™, Oxygen Reserve Index, to Help Suppress Postoperative Hyperoxia in Patients Undergoing... -Monday 14 December 2020  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the findings of an abstract recently presented at Euroanaesthesia 2020 in which Dr. Kumagai and colleagues at Iwate Medical University Hospital in Yahaba-cho, Japan investigated whether Masimo ORi™, Oxygen Reserve Index, could be used to...

New Study Associates Masimo SpHb®, Noninvasive and Continuous Hemoglobin Monitoring, as Part of Pediatric Patient... -Monday 14 December 2020  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the findings of an abstract recently presented at Euroanaesthesia 2020 in which Dr. Saraçoğlu and colleagues at Marmara University in Istanbul, Turkey investigated the efficacy of Masimo noninvasive and continuous hemoglobin...